The changing role of surgery in metastatic non-seminomatous germ cell tumour
1992

Surgery's Role in Treating Metastatic Germ Cell Tumors

Sample size: 53 publication Evidence: moderate

Author Information

Author(s): J. Cassidy, C.R. Lewis, S.B. Kaye, D. Kirk

Primary Institution: Western Infirmary, Glasgow, UK

Hypothesis

Can interventional surgery improve outcomes for patients with metastatic non-seminomatous germ cell tumors who are not responding to chemotherapy?

Conclusion

Interventional surgery can lead to a rapid decrease in tumor markers and disease-free status in selected patients with metastatic non-seminomatous germ cell tumors.

Supporting Evidence

  • Surgery was performed on three patients with rising tumor markers, leading to a fall in markers and disease-free status.
  • The overall cure rate for non-seminomatous germ cell tumors is around 90%, but lower for advanced cases.
  • Interventional surgery was shown to convert patients from a drug-resistant phase to a curable situation.

Takeaway

Some patients with advanced testicular cancer can get better if doctors remove the biggest tumor, even if the cancer isn't responding to medicine.

Methodology

The study involved treating 53 patients with metastatic teratoma, with 13 requiring surgical excision of abdominal masses, and 3 undergoing surgery as a therapeutic intervention.

Limitations

The study is based on a small subgroup of patients and may not be generalizable to all cases.

Participant Demographics

Patients included 28 and 22-year-old males with varying presentations of metastatic teratoma.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication